Last update 19 Jun 2024

Anti-BCMA CARNK-cell therapy (Takeda)

Overview

Basic Info

Drug Type
CAR-NK
Synonyms
AntiBCMA CAR NKcell therapy Takeda, B-cell maturation antigen (BCMA)-targeted CAR NK-cell therapy
Target
BCMA x IL15R
Mechanism
BCMA inhibitors(B-cell maturation protein inhibitors), IL15R agonists(Interleukin-15 receptors agonists), Immunologic cytotoxicity
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [1]
Active Indication
Mature B-Cell NeoplasmMultiple MyelomaNeoplasms
Inactive Indication-
Originator Organization
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.Anderson UniversityAnderson UniversityThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
Active Organization
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.Anderson UniversityAnderson UniversityThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Anti-BCMA CARNK-cell therapy (Takeda)
Login to view more data
100 Translational Medicine associated with Anti-BCMA CARNK-cell therapy (Takeda)
Login to view more data
100 Patents (Medical) associated with Anti-BCMA CARNK-cell therapy (Takeda)
Login to view more data
100 Deals associated with Anti-BCMA CARNK-cell therapy (Takeda)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mature B-Cell NeoplasmPreclinical
US
The University of Texas MD Anderson Cancer Center
15 Nov 2022
Mature B-Cell NeoplasmPreclinical
JP
Takeda Pharmaceutical Co., Ltd.
15 Nov 2022
Multiple MyelomaPreclinical
US
The University of Texas MD Anderson Cancer Center
15 Nov 2022
Multiple MyelomaPreclinical
JP
Takeda Pharmaceutical Co., Ltd.
15 Nov 2022
NeoplasmsPreclinical
US
Takeda Pharmaceutical Co., Ltd.
-
NeoplasmsPreclinical
US
Anderson UniversityAnderson University
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free